Acquisition synergies PL Developments has just been acquired by Top Gum Ltd for up to 35 million, signaling a potential channel expansion, cross-sell opportunities, and combined manufacturing capacity to support broader private-label and contract manufacturing deals in North America.

Private-label scale As the second-largest private-label OTC manufacturer with over 2 million square feet across seven FDA-registered U.S. facilities and more than 20 billion dosages annually, PLD offers extensive capacity and proven compliance to support large retailers and new private-label partnerships.

Formulation library With a library of 600+ formulations and 60+ ANDAs, PLD presents a strong development platform for brands seeking rapid product launches, modernization, or regulatory-driven reformulations in OTC, solid dosage, liquids, and gummies.

Global retail reach Serving every major U.S. retailer and many international customers, PLD’s market presence and distribution footprint enable introductions to new regional customers and co-pack opportunities across multiple categories.

Quality and compliance PLD emphasizes cGMP, FDA compliance, ISO 13485 alignment, and a robust tech stack, offering a trusted, scalable manufacturing partner ideal for brands prioritizing quality assurance, regulatory readiness, and efficiency in supply.